Total Valuation
Kraig Biocraft Laboratories has a market cap or net worth of $123.44M. The enterprise value is $121.19M.
Market Cap$123.44M
Enterprise Value$121.19M
Share Statistics
Kraig Biocraft Laboratories has 1,113,049,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,113,049,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kraig Biocraft Laboratories’s return on equity (ROE) is 0.45 and return on invested capital (ROIC) is 53.27%.
Return on Equity (ROE)0.45
Return on Assets (ROA)-1.41
Return on Invested Capital (ROIC)53.27%
Return on Capital Employed (ROCE)0.43
Revenue Per Employee0.00
Profits Per Employee-258.81K
Employee Count14
Asset Turnover0.00
Inventory Turnover0.86
Valuation Ratios
The current PE Ratio of Kraig Biocraft Laboratories is ―. Kraig Biocraft Laboratories’s PEG ratio is -8.30.
PE Ratio―
PS Ratio0.00
PB Ratio-11.32
Price to Fair Value-11.32
Price to FCF-50.48
Price to Operating Cash Flow>-0.01
PEG Ratio-8.30
Income Statement
In the last 12 months, Kraig Biocraft Laboratories had revenue of 0.00 and earned -3.62M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-25.11K
Operating Income-3.37M
Pretax Income-3.62M
Net Income-3.62M
EBITDA-3.03M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.79T and capital expenditures -5.40B, giving a free cash flow of -1.79T billion.
Operating Cash Flow-1.79T
Free Cash Flow-1.79T
Free Cash Flow per Share-1.61K
Dividends & Yields
Kraig Biocraft Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change27.91%
50-Day Moving Average0.13
200-Day Moving Average0.10
Relative Strength Index (RSI)47.98
Average Volume (3m)1.34M
Important Dates
Kraig Biocraft Laboratories upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Kraig Biocraft Laboratories as a current ratio of 0.18, with Debt / Equity ratio of -23.37%
Current Ratio0.18
Quick Ratio0.18
Debt to Market Cap0.02
Net Debt to EBITDA0.04
Interest Coverage Ratio-5.91
Taxes
In the past 12 months, Kraig Biocraft Laboratories has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Kraig Biocraft Laboratories EV to EBITDA ratio is -29.88, with an EV/FCF ratio of -50.41.
EV to Sales0.00
EV to EBITDA-29.88
EV to Free Cash Flow-50.41
EV to Operating Cash Flow-50.56
Balance Sheet
Kraig Biocraft Laboratories has $2.89M in cash and marketable securities with $1.65M in debt, giving a net cash position of $1.24M billion.
Cash & Marketable Securities$2.89M
Total Debt$1.65M
Net Cash$1.24M
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Kraig Biocraft Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-8.82%